chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever 103, chills, not making sense, HA, not feeling good. Blood work, CXR, Tylenol and ibuprofen, IVF.
Vomiting dizzy fainting jerking on right side in pain then she couldn't hardly speak acting crazy at times couldnt walk or feed herself. She got anti-NMDA receptor encephalitis from it and seizures and she Guillain Barre syndrome.
Myalgia, Arthralgia, CHILLS, FATIGUE, BODY ACHES Narrative:
Rash that started on face and has now spread down to her chest and upper back. Starting on 6/24 and continued currently.
No adverse effect, the vaccine was administered after the expiry which was 9/30/22. but per Pfizer the vaccine is stable until 10/19/22
Child was accidentally given the vaccines meant for her 4 year old sibling.  This child only required one Dtap to complete her vaccine schedule.   No effects were observed in 30 minutes post injection.  Mother informed of mistake and understood there are no expected adverse effects from having received these extra doses.
Presented with c/o fever, chills, shortness of breath along with cough and chest congestion.  Patient tested positive for COVID-19. Tx w/steroids, zinc, VitC; did not require O2. Dc'd home.
trouble sleeping; Fatigue,; general muscle soreness all over; injection site soreness; skin redness at injection site; headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 23Mar2021 at 11:00 (at the age 48-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, GERD and sleep apnea. The patient was allergic to casein and dust mites. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), paracetamol (TYLENOL), pravastatin (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and ESCILOP, all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 01Mar2021 at 10:30 (at the age 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 23:00, the patient experienced fatigue, general muscle soreness all over, injection site soreness, skin redness at injection site, headaches and had trouble sleeping. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient received treatment with paracetamol (TYLENOL) for the events fatigue, general muscle soreness all over, injection site soreness, skin redness at injection site, headaches and trouble sleeping. The clinical outcomes of the events fatigue, general muscle soreness all over, injection site soreness, skin redness at injection site, headaches and trouble sleeping were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
I received the vaccine on Jan 12.  Late morning on Jan 20, I began having chest pain located on the center left side of my chest. It hurt most when I bent over and when I laid down.  I got an appt to see my PCP on Jan 21, she had no idea what was going on but scheduled me for a CT for Jan 22.  I never made the CT appt because on the evening of Thursday, Jan 21, I began having an erratic heartbeat and thought I was having a heart attack.  I went to the emergency department and they found that I was in AFIB.  I have never had AFIB before or since this.  I was kept overnight and had many tests run.  I saw my cardiologist days after and was told that I likely had pericarditis due to my symptom of pain when bending and laying down.    I have never had pericarditis or AFIB before or since then.
Within five minutes of getting the vaccine I had a horrible taste in my mouth. As soon as I got home I slept for 18 hours. I woke up with a horrible headache and diarrhea that lasted for 2 days. Today, most recently, I have had a temperature, nausea and vomiting. I had contacted my DR for a telehealth visit when I had the diarrhea 8/23/2021 and to see if I could be treated. The DR said I could treat at home.
patient's husband reports it was mental distortion the night after taking the vaccine with some memory loss the following day.  husband also reported fever, hypertension ,and extreme fatigue the night of the vaccine.  The paramedics had to be called
No significant effects immediate, minor soreness injection site. 8 days after 1st dose Moderna vaccine, approximately 10 cm area warmness, swelling , redness and itching at injection site. Topical benadryl, and steroid cream used for says. Persistent but no worsening at 2 day.lamine  Note I listed previous topical sensitivities to myristates, triethanolamine etc- but nothing this marked.
Pt came into pharmacy with a complaint of redness and warmth around the area where vaccination took place. She stated that it has hurt all week but is now red and a lump has formed where the vaccine was administered. I counselled the patient to seek a doctor as this could be an infection.
1 wk post vaccine child had an episode of shaking: starring off, red blotchy skin all over her body and arms and hand turned blue, episode lasted 15 minutes with temp of 104.2 followed by 45 mins of lethargy. Cont. to have temp of 104 post episode, tx ER notified when episode happened. Client saw Dr 11/12/03 with labs completed, temp broke 11/15/03. Red rash all over body 11/16/03 and lasted 24-36 hrs.
Patient seen in office today (4/10/18), presented with night leg with 2 cm area of redness, sl warmth, and sl fullness. Noted to might be slightly tender. Clearly at site of vaccine. Knee and hip with full range of motion without discomfort. Diagnosed with cellulitis of right lower extremity prescribed antibiotic cephalexin.
Started feeling a little off with a fever. Took home COVID-19 test and was positive. Called doctor and had a Telehealth visit and was prescribed remdesivir. Started feeling better 4 days later.
Well I am guessing that within a week or two I went to a regular annual exam with my DR and I ended up having precancerous lesions. I had to have CRYO therapy in March 2021 and then had to be checked a few extra times, I just did my six month exam now because they have to keep an eye on me now. I have never had cancerous anything before. We are waiting on results from that. That is extremely scary and honestly painful because of the CRYO therapy.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore and tender arm around the injection site), tenderness (sore and tender arm), pyrexia (fever) and chills in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026120A) for COVID-19 immunization. No medical history reported. On Jan 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; unspecified dose. On an unknown date, patient experienced pain in extremity (sore and tender arm around the injection site), tenderness (sore and tender arm), pyrexia (fever) and chills. At the time of the report, pain in extremity (sore and tender arm around the injection site), tenderness (sore and tender arm), pyrexia (fever) and chills outcome: unknown. mRNA-1273 (Moderna COVID-19 vaccine), intramuscular and mRNA-1273 (Moderna COVID-19 vaccine), unknown route; dosing remained unchanged. Action taken with mRNA-1273 in response to the drug: no change. No concomitant medication or treatment information provided. This case linked to MOD-2021-039052 (patient link).
This spontaneous report was received from a nurse and health professional and refers to a  year old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 27-JAN-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck), lot # L030586, expiry date: 10-FEB-2017 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
I have experienced severe pain in me feet beginning in August 2021. I have pain in my achilles and arches which led to difficulty walking. This pain has progressively gotten worse since then. I feel pain in my nerves and muscles in my feet, calves, knees, and tibialis muscles. I have seen a podiatrist and have had multiple tests done. I now have neuropathy, Morton?s neuroma, tarsel tunnel syndrome, and plantar fasciitis. I also have heel pain and sensitivity on the tops of my feet which get irritated by shoes. This has affected my ability to perform to my usual ability at work. I came down with Covid-19 in January 2022 and January of 2023 and both times I had sever reactions which affected my asthma and my feet became extremely inflamed afterwards, leading to months of pain and recovery. I cannot was without specialized orthotic inserts. I can never walk barefoot, even in my own home. I have seen physical therapists, podiatrists, and doctors. I have also seen a neurologist. They are all trying to get to the bottom of these issues. Nothing has improved the pain thus far.
Extreme vertigo that makes it almost impossible to walk. Started 6 hours after shot and has continue to 36 hours.
sore throat with yellow mucous; sore throat with yellow mucous; congestion; chills; fever of 102; headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SECRETION DISCHARGE (sore throat with yellow mucous), OROPHARYNGEAL PAIN (sore throat with yellow mucous), NASAL CONGESTION (congestion), CHILLS (chills) and PYREXIA (fever of 102) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN (MOTRIN CHILDREN), LORATADINE, DEXTROMETHORPHAN POLISTIREX (ROBITUSSIN 12 HOUR COUGH RELIEF), EUCALYPTUS GLOBULUS OIL, MENTHOL (HALLS) and XYLOMETAZOLINE HYDROCHLORIDE (NASAL SPRAY II) for an unknown indication.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 02-Apr-2021, the patient experienced SECRETION DISCHARGE (sore throat with yellow mucous), OROPHARYNGEAL PAIN (sore throat with yellow mucous), NASAL CONGESTION (congestion), CHILLS (chills), PYREXIA (fever of 102) and HEADACHE (headache). At the time of the report, SECRETION DISCHARGE (sore throat with yellow mucous), OROPHARYNGEAL PAIN (sore throat with yellow mucous), NASAL CONGESTION (congestion), CHILLS (chills), PYREXIA (fever of 102) and HEADACHE (headache) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.
1st dose April 2022, 2nd 7.5 months later; feverish; This case was reported by a consumer via call center representative and described the occurrence of fever in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (The patient received 1st dose of Shingrix in Apr 2022).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced fever and drug dose administration interval too long. On an unknown date, the outcome of the fever was recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.     Additional Information: GSK Receipt Date: 07-DEC-2022 Reporter's Comment: The case was self reported by the patient. The patient received second dose of Shingrix 7.5 months after the first dose of Shingrix and felt feverish, but that the feverish feeling went away after one day. No further information reported to the agent by the patient. The reporter did not consent to follow up. Additional supportive information: The patient received the second dose of Shingrix later than the recommended interval, which led to lengthening of vaccination schedule
As of now, he is still having trouble moving his neck; It's painful to touch; On both arm, he still has joint pain on shoulders; 2 days after receiving 1st dose, patient's neck and muscle injuries were activated/When he woke up, he could barely move his neck; This spontaneous case was reported by a consumer and describes the occurrence of NECK INJURY (2 days after receiving 1st dose, patient's neck and muscle injuries were activated/When he woke up, he could barely move his neck), NUCHAL RIGIDITY (As of now, he is still having trouble moving his neck), PAIN (It's painful to touch) and ARTHRALGIA (On both arm, he still has joint pain on shoulders) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included Neck injury.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced NECK INJURY (2 days after receiving 1st dose, patient's neck and muscle injuries were activated/When he woke up, he could barely move his neck). On 26-Mar-2021, the patient experienced NUCHAL RIGIDITY (As of now, he is still having trouble moving his neck), PAIN (It's painful to touch) and ARTHRALGIA (On both arm, he still has joint pain on shoulders). The patient was treated with HYDROCODONE at an unspecified dose and frequency. At the time of the report, NECK INJURY (2 days after receiving 1st dose, patient's neck and muscle injuries were activated/When he woke up, he could barely move his neck), NUCHAL RIGIDITY (As of now, he is still having trouble moving his neck), PAIN (It's painful to touch) and ARTHRALGIA (On both arm, he still has joint pain on shoulders) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided.
Fingers hurt; hands swollen; wrist - ankles swelling; her joints in her body all at one time started hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Fingers hurt), PERIPHERAL SWELLING (hands swollen), JOINT SWELLING (wrist - ankles swelling) and ARTHRALGIA (her joints in her body all at one time started hurting) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (Fingers hurt), PERIPHERAL SWELLING (hands swollen), JOINT SWELLING (wrist - ankles swelling) and ARTHRALGIA (her joints in her body all at one time started hurting). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Fingers hurt), PERIPHERAL SWELLING (hands swollen), JOINT SWELLING (wrist - ankles swelling) and ARTHRALGIA (her joints in her body all at one time started hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication include Tylenol . Patient already had both shots but a week after first shot this happened. It has intensified since then, took her to the emergency room, they only did some lab work and told her to take Tylenol but it is not helping. Had first shot on March 16th 2021 in her left arm and a week after first shot, maybe this would be on the week of the 28th or 29th of March, she says that all her joints in her body all at one time started hurting. Getting worse, for example she can't even cover herself because when she touches the blanket her fingers hurt. Her hands, wrists and ankles are all swollen. Talked to friends and we know that some had joint pains and it is normal from the vaccine but they it went away.  She had lab work done, and they came back normal except for the liver, the liver count was high. She had second shot of Moderna vaccine on April 18th 2021 in her right arm. Didn't have lot number to be able to provide, nor expiration date. Said she had a cold, never was sick, never had to be in hospital. No concomitant medicine, only has vitamins.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. In 2015 these patients were vaccinated with doses of VAQTA (lot # k018181 with expiration 04-JUN-2017; lot # L028666 with expiration 04-NOV-2016; lot # K026529 with expiration 02-JUN-2017; lot#/batch# was reported as L007569 with expiration date 01-JUN-2017, dose, frequency and route were not reported, which had been improperly stored since January 2015 (incorrect product storage). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
Body Swelling; eyes on fire; eyes completely puffy; extremely Migraine; vision went blurry; Dizzy; could not keep her balance; eyes completely red; body ache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SWELLING (Body Swelling), EYE IRRITATION (eyes on fire), PERIORBITAL SWELLING (eyes completely puffy), MIGRAINE (extremely Migraine), VISION BLURRED (vision went blurry), DIZZINESS (Dizzy), BALANCE DISORDER (could not keep her balance), OCULAR HYPERAEMIA (eyes completely red) and MYALGIA (body ache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced SWELLING (Body Swelling) (seriousness criterion hospitalization), EYE IRRITATION (eyes on fire) (seriousness criterion hospitalization), PERIORBITAL SWELLING (eyes completely puffy) (seriousness criterion hospitalization), MIGRAINE (extremely Migraine) (seriousness criterion hospitalization), VISION BLURRED (vision went blurry) (seriousness criterion hospitalization), DIZZINESS (Dizzy) (seriousness criterion hospitalization), BALANCE DISORDER (could not keep her balance) (seriousness criterion hospitalization), OCULAR HYPERAEMIA (eyes completely red) (seriousness criterion hospitalization) and MYALGIA (body ache) (seriousness criterion hospitalization). The patient was hospitalized from 26-Apr-2021 to 27-Apr-2021 due to BALANCE DISORDER, DIZZINESS, EYE IRRITATION, MIGRAINE, MYALGIA, OCULAR HYPERAEMIA, PERIORBITAL SWELLING, SWELLING and VISION BLURRED. At the time of the report, SWELLING (Body Swelling), EYE IRRITATION (eyes on fire), PERIORBITAL SWELLING (eyes completely puffy), MIGRAINE (extremely Migraine), VISION BLURRED (vision went blurry), DIZZINESS (Dizzy), BALANCE DISORDER (could not keep her balance), OCULAR HYPERAEMIA (eyes completely red) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment included Adrenaline (Epinephrine).  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
A non-serious spontaneous report of inadvertent administration of expired H1N1 was received from a registered nurse/health professional concerning a six-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessment was not applicable and the event was considered to be resolved.
Initially on 9/19/11 pt. c/o soreness in left deltoid at injection site. The next day he reported a tingling radiating down the left arm into the left baby finger. A quarter sized area of erythema was noted at the injection site on 9/22/11 as well as a redness to the anterior forearm. Also at the left wrist several very small red blistery areas were noted. Left deltoid is tender to touch (#5) on scale. T. 99 P.O BP 130/70 - 104 is reg - 16. Pt went to ER, ER MD felt infection was a result of resident bacteria on body due to tracheostomy not removable with alcohol wipe. Rx with erythromycin 2 times daily P.O. Tingling sensation is gone as of 9/23/11 cold packs to left forearm to f/u with PCP / pt is wearing sling dx staph infection. No erythema (L) deltoid noted.
Patient could not walk; Bedridden; This spontaneous case was reported by a patient and describes the occurrence of GAIT INABILITY (Patient could not walk) and BEDRIDDEN (Bedridden) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 025C21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jun-2021, the patient experienced GAIT INABILITY (Patient could not walk) and BEDRIDDEN (Bedridden). At the time of the report, GAIT INABILITY (Patient could not walk) and BEDRIDDEN (Bedridden) outcome was unknown.  Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
This spontaneous report was received from a medical assistant refers to multiple unspecified patients of unknown gender and age. Information regarding the patients' medical history, concurrent conditions, drug reactions/allergies and concomitant therapy were not provided. On unknown dates, these patients were vaccinated with doses of improperly stored VAQTA (lot # K019560, expiry date: 12-JUN-2017). Medical assistant reported that the vaccines went to  31.8 F for 7 hours and 45 minutes. They were logged by a data logger and there were no prior excursions. The vaccines were back in range. No adverse effect were reported. This is one of five reports received from the same reporter. Additional information has been requested.
Employee complained of feeling very warm and was having tremor in right calf. Benadryl, 50 mg was given IM left deltoid. Monitored X 45 minutes. Feeling better. BP-140/90.
pt recv vax 12APR97 & pt exp urticaria & pruritus;the urticaria rash was located on trunk, rt axillary area & looked like folliculitis;pt was treated w/cephalexin & hydrocortisone for itching;
pt was given an expired dose from previous day that was not discarded properly.  RPH called Pfizer to get direction and they advised to revaccinate in opposite arm the following day